Treatment of cancer and compositions

Details for Australian Patent Application No. 2005295130 (hide)

Owner John Wayne Cancer Institute

Inventors Essner, Richard

Agent FB Rice

Pub. Number AU-A-2005295130

PCT Pub. Number WO2006/042328

Priority 60/618,409 12.10.04 US

Filing date 12 October 2005

Wipo publication date 20 April 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/042328 Priority application(s): WO2006/042328

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295131-CRIg polypeptide for prevention and treatment of complement-associated disorders

2005295128-Log-likelihood estimation based on channel estimation errors due to guard subbands